标题title
N-芳基吲哚类化合物及其合成方法
摘要abst
本发明公开了一种N‑芳基吲哚类化合物及其合成方法，属于有机合成技术领域。以邻烯基苯胺类化合物1和重氮萘酮类化合物2为原料，在过渡金属催化剂2和空气存在下，有机溶剂中升温反应，得到N‑芳基吲哚类化合物3；该合成方法通过邻烯基苯胺类化合物和重氮萘酮类化合物之间的串联反应高效完成，具有底物易得、反应条件温和且无需使用添加剂、原子经济性高以及底物适用范围广等优点。
权利要求书clms
1.N-芳基吲哚类化合物，其特征在于，结构通式为：其中：R1为氢、C1-4链状烷基、C1-4链状烷氧基、卤素、氰基、硝基、甲叉二氧基中的一种或两种取代，R2为C1-4链状烷基、C5-6环状烷基、苯基或取代苯基，取代苯基中取代基为C1-4链状烷基、C1-4链状烷氧基或卤素，R3为C1-4链状烷基、C1-4链状烷氧基、C5-6环状烷基、卤素、氰基、醛基、乙酰基、羟基、萘基、苯基或取代苯基，取代苯基苯环上的取代基为C1-4链状烷基或卤素。2.如权利要求1所述N-芳基吲哚类化合物的合成方法，其特征在于，包括如下操作：以邻烯基苯胺类化合物1和重氮萘酮类化合物2为原料，在过渡金属催化剂和氧化剂存在下，有机溶剂中升温反应，得到N-芳基吲哚类化合物3；反应方程式为：其中：所述取代基与权利要求1中一致。3.根据权利要求2所述N-芳基吲哚类化合物的合成方法，其特征在于：所述过渡金属催化剂为2、CoCp*I2、RuCl2或RuCl3。4.根据权利要求2所述N-芳基吲哚类化合物的合成方法，其特征在于：所述有机溶剂为四氢呋喃、1,2-二氯乙烷、乙腈、甲醇、甲苯、乙二醇二甲醚、三氟乙醇或1,4-二氧六环。5.根据权利要求2所述N-芳基吲哚类化合物的合成方法，其特征在于：所述氧化剂选自空气或氧气。6.根据权利要求2所述N-芳基吲哚类化合物的合成方法，其特征在于：所述邻烯基苯胺类化合物1、重氮萘酮类化合物2与催化剂摩尔比为1:1-2:0.025-0.05。7.根据权利要求2所述N-芳基吲哚类化合物的合成方法，其特征在于：对于R2为苯基或取代苯基底物时，反应体系中添加催化量AgSbF6。8.根据权利要求2-7任意一项所述N-芳基吲哚类化合物的合成方法，其特征在于：升温反应温度为60-100℃。
说明书desc
技术领域本发明属于有机合成技术领域，具体涉及一种N-芳基吲哚类化合物的合成方法。背景技术吲哚是许多天然产物、上市药物、功能材料和农药的核心结构单元。在众多吲哚衍生物中，N-芳基取代吲哚因具有显著生物活性和药理特性而备受关注，目前已被开发为血清素5-HT2受体、多巴胺D2受体、肾上腺素受体拮抗剂、人胰高血糖素受体拮抗剂、胞质磷脂酶A2α抑制剂和5-羟色胺5-HT7拮抗剂等。此外，N-芳基吲哚还是合成天然生物碱和荧光探针的关键中间体。目前，N-芳基吲哚主要通过以下方法合成：钯催化下邻炔基卤代芳烃的胺化和环化、钯/铜催化下2-芳基卤化物与胺的串联反应、苯介导的2-芳基-3-芳基氨基-2-烯腈的氧化环化、钯催化下芳烃与N-芳基-β-氨基酮的杂环化、铁催化下二炔与吲哚-N-炔烃的环加成反应、钯催化下碘芳烃、炔烃和胺之间的串联反应等。上述方法尽管大多是有效且可靠的，但它们大多需要使用卤代等高度官能团化的底物，且反应条件苛刻，不宜扩大合成规模，这在很大程度上影响了其总效率、可持续性、原子经济性和实用性。因此，研究并开发从价廉易得的原料出发、在相对温和反应条件下制备N-芳基吲哚衍生物的新方法，具有重要的理论意义和应用价值。发明内容本发明解决的技术问题是提供了一类N-芳基吲哚类化合物及其合成方法，该合成方法通过邻烯基苯胺类化合物和重氮萘酮类化合物之间的串联反应高效完成，具有底物易得、反应条件温和且无需使用添加剂、原子经济性高以及底物适用范围广等优点。本发明所提供的N-芳基吲哚类化合物，其结构通式为：其中：R1为氢、C1-4链状烷基、C1-4链状烷氧基、卤素、氰基、硝基、甲叉二氧基中的一种或两种取代，R2为C1-4链状烷基、C5-6环状烷基、苯基或取代苯基，取代苯基中取代基为C1-4链状烷基、C1-4链状烷氧基或卤素，R3为C1-4链状烷基、C1-4链状烷氧基、C5-6环状烷基、卤素、氰基、醛基、乙酰基、羟基、萘基、苯基或取代苯基，取代苯基苯环上的取代基为C1-4链状烷基或卤素。本发明还提供了上述N-芳基吲哚类化合物的合成方法，包括如下操作：以邻烯基苯胺类化合物1和重氮萘酮类化合物2为原料，在过渡金属催化剂和氧化剂存在下，有机溶剂中升温反应，得到N-芳基吲哚类化合物3。反应方程式为：其中：R1为氢、C1-4链状烷基、C1-4链状烷氧基、卤素、氰基、硝基或甲叉二氧基中的一种或两种取代，R2为C1-4链状烷基、C5-6环状烷基、苯基或取代苯基，取代苯基苯环上的取代基为C1-4链状烷基、C1-4链状烷氧基或卤素，R3为C1-4链状烷基、C1-4链状烷氧基、C5-6环状烷基、卤素、氰基、醛基、乙酰基、羟基、萘基、苯基或取代苯基，取代苯基苯环上的取代基为C1-4链状烷基或卤素。进一步地，在上述技术方案中，所述过渡金属催化剂为二氯双钌、五甲基环戊二烯基羰基二碘合钴I2)、环辛二烯二氯化钌Cl2)或三氯化钌。进一步地，在上述技术方案中，所述有机溶剂为四氢呋喃、1,2-二氯乙烷、乙腈、甲醇、甲苯、乙二醇二甲醚、三氟乙醇或1,4-二氧六环。进一步地，在上述技术方案中，所述氧化剂选自空气或氧气，优选自空气。进一步地，在上述技术方案中，所述邻烯基苯胺类化合物1、重氮萘酮类化合物2与过渡金属催化剂摩尔比为1:1-2:0.025-0.05。进一步地，在上述技术方案中，对于R2为苯基或取代苯基底物时，反应体系中添加催化量AgSbF6，用以提高反应收率。进一步地，在上述技术方案中，所述反应温度为60-100℃。发明有益效果：本发明与现有技术相比具有以下优点：通过邻烯基苯胺类化合物和重氮萘酮类化合物的一锅串联反应，直接合成出N-芳基吲哚类化合物，即：反应在构建出吲哚骨架的同时将芳基单元接枝到吲哚环，具有过程简单、原子经济性高的特点；反应条件温和，操作简便；原料廉价易得、底物适用范围广、官能团耐受性好；采用空气作为氧化剂，具有绿色、经济和可持续的特点。说明书附图图1为实施例3中化合物3c的X-射线单晶衍射图。具体实施方式以下通过实施例对本发明的上述内容做进一步详细说明，但不应该将此理解为本发明上述主题的范围仅限于以下的实施例，凡基于本发明上述内容实现的技术均属于本发明的范围。实施例1向15mL反应管中依次加入化合物1a、2a、金属催化剂和有机溶剂，在空气条件下将反应管密封，将其置于加热模块中升温搅拌反应。待反应结束后，冷却至室温，用硅藻土过滤，滤液浓缩，过硅胶柱分离得到黄色油状产物3a。通过改变反应的金属催化剂、有机溶剂、反应温度和物料比等反应条件，得到一系列的结果，见表1。表1不同条件下3a的合成a实施例2向15mL耐压管中依次加入1a、2a、2和1,4-二氧六环，然后将反应管密封，将其置于90℃油浴中反应4h。反应结束后，将反应体系冷却至室温，硅藻土过滤，滤液浓缩，硅胶柱分离得到黄色油状产物3a。该化合物的表征数据为：1H NMR:δ7.88,7.85-7.83,7.70,7.36-7.27,7.22-7.19,7.14,6.98-6.96,6.88,5.30,2.45.13C{1H}NMR:δ150.8,137.7,132.3,130.3,129.3,129.2,128.1,127.5,126.7,124.1,122.9,121.8,120.2,119.3,117.9,117.5,113.9,110.5,9.8.HRMSm/z:+Calcd forC19H16NO 274.1226；Found 274.1214.实施例3依照实施例2的方法和步骤a,b，通过改变反应物1和反应物2，可以合成出各种N-芳基吲哚类化合物3，具体反应结果如下：a反应条件：1,2,2,1,4-二氧六环,升温至90℃，4h,空气氛围；b分离收率；cAgSbF6。代表性产物表征数据如下：1-naphthalen-2-ol1H NMR:δ7.86,7.83,7.49,7.34-7.32,7.30-7.27,6.98-6.96,6.94,6.77,5.31,2.49,2.42.13C{1H}NMR:δ150.8,136.1,132.4,130.3,129.6,129.5,129.2,128.1,127.5,126.9,124.4,124.1,121.9,119.0,118.1,117.5,113.4,110.2,21.5,9.8.HRMSm/z:+Calcd for C20H18NO 288.1383；Found 288.1376.1-naphthalen-2-ol1H NMR:δ7.87,7.83,7.35-7.29,7.13,6.98-6.97,6.81-6.76,5.36,3.89,2.41.13C{1H}NMR:δ154.7,150.8,132.9,132.4,130.3,129.6,129.2,128.1,127.52,127.49,124.1,121.8,118.0,117.5,113.5,112.8,111.3,101.2,56.0,9.9.HRMSm/z:+Calcd for C20H18NO2304.1332；Found304.1324.1-naphthalen-2-ol1H NMR:δ7.88,7.85-7.83,7.37-7.29,7.02,6.94-6.91,6.87,6.77,5.28,2.40.13C{1H}NMR:δ158.4,150.7,134.2,132.3,130.6,129.6,129.2,128.5,128.2,127.7,124.2,121.6,117.7,117.5,113.8,111.3,111.2,104.4,9.8.19F NMR:δ-123.79.HRMSm/z:+Calcd for C19H15FNO 292.1132；Found 292.1119.1-naphthalen-2-ol1H NMR:δ7.89,7.85,7.67,7.37-7.31,7.09,7.01,6.92,6.79,5.21,2.41.13C{1H}NMR:δ150.7,136.1,132.2,130.6,130.3,129.2,128.2,128.1,127.7,126.1,124.2,123.2,121.5,118.9,117.5,117.4,113.6,111.6,9.7.HRMSm/z:+Calcdfor C19H15ClNO 308.0837；Found 308.0830.1-naphthalen-2-ol1H NMR:δ7.80,7.77-7.74,7.28-7.21,7.12,6.90,6.82,6.65,5.14,2.32.13C{1H}NMR:δ150.7,136.4,132.2,131.0,130.7,129.2,128.2,128.0,127.7,125.7,124.3,122.1,121.5,117.6,117.4,113.7,113.5,112.1,9.7.HRMSm/z:+Calcd for C19H15BrNO352.0332；Found 352.0312.1--3-methyl-1H-indole-5-carbonitrile1H NMR:δ8.02,7.93,7.88,7.40-7.33,7.13,6.93,6.87,5.34,2.47.13C{1H}NMR:δ150.7,139.4,131.9,131.0,129.2,129.1,129.0,128.3,127.9,125.7,125.0,124.4,121.2,120.5,117.7,116.8,114.6,111.5,103.2,9.6.HRMSm/z:+Calcd for C20H15N2O299.1179；Found 299.1171.1-naphthalen-2-ol1H NMR:δ8.65,8.02,7.94,7.89,7.41-7.35,7.16,6.91-6.89,5.32,2.50.13C{1H}NMR:δ150.6,142.2,140.6,131.8,131.2,129.9,129.3,128.6,128.4,128.0,124.5,121.1,118.4,117.7,116.8,116.7,116.2,110.6,9.7.HRMSm/z:+Calcd for C19H15N2O3319.1077；Found 319.1070.1-naphthalen-2-ol1H NMR:δ7.88,7.85,7.58,7.36-7.33,7.32-7.30,7.04,7.00,6.90,6.68,5.30,2.42,2.33.13C{1H}NMR:δ150.7,138.1,132.9,132.4,130.3,129.2,128.1,127.5,127.2,126.1,124.1,122.0,121.9,119.0,118.0,117.5,113.8,110.3,21.7,9.9.HRMSm/z:+Calcd for C20H18NO 288.1383；Found 288.1376.1--3-methyl-1H-indol-1-yl)naphthalen-2-ol1H NMR:δ7.89,7.86,7.64,7.38-7.30,7.06,6.93,6.86,5.29,2.43,1.25.13C{1H}NMR:δ150.6,146.7,137.6,132.3,130.2,129.3,128.1,127.4,127.1,126.5,124.1,122.1,118.7,118.5,118.0,117.6,113.6,106.6,34.9,31.8,9.8.HRMSm/z:+Calcd for C23H24NO 330.1852；Found 330.1838.1-naphthalen-2-ol1H NMR:δ7.89,7.85,7.56,7.37-7.32,7.03,6.88-6.86,6.33,5.33,3.65,2.41.13C{1H}NMR:δ157.3,150.7,138.5,132.2,130.3,129.2,128.1,127.5,125.4,124.1,123.5,121.9,120.0,117.9,117.5,113.9,110.3,93.7,55.7,9.9.HRMSm/z:+Calcd forC20H18NO2304.1332；Found 304.1320.1-naphthalen-2-ol1H NMR:δ7.87,7.83,7.56,7.34-7.30,7.12,6.90,6.85,6.82,5.40,2.41,1.76.13C{1H}NMR:δ151.1,136.6,133.6,130.4,130.1,128.5,128.0,127.85,127.75,125.0,124.1,122.2,121.6,120.5,120.4,117.3,116.9,114.0,17.1,9.8.HRMSm/z:+Calcd for C20H18NO 288.1383；Found 288.1376.1-naphthalen-2-ol1H NMR:δ7.87,7.82,7.34-7.28,6.84-6.82,6.74,5.42,2.46,2.38,1.72.13C{1H}NMR:δ151.1,134.9,133.6,130.35,130.28,129.8,128.5,128.0,127.7,126.7,124.1,121.9,121.7,120.5,116.93,116.90,113.6,21.3,16.9,9.8.HRMSm/z:+Calcd for C21H20NO 302.1539；Found302.1530.1-naphthalen-2-ol1H NMR:δ7.87,7.85-7.82,7.35-7.31,7.03,7.00-6.97,6.86,6.30,5.87,5.35,2.36.13C{1H}NMR:δ150.7,145.7,143.5,132.9,132.2,130.4,129.2,128.1,127.6,125.4,124.1,123.2,121.8,118.0,117.5,114.0,100.8,97.9,91.6,9.9.HRMSm/z:+Calcd for C20H16NO3318.1125；Found318.1108.1-naphthalen-2-ol1H NMR:δ7.89,7.86-7.84,7.75-7.73,7.37-7.29,7.21,7.15,7.00,6.97,6.89,5.30,2.91,1.41.13C{1H}NMR:δ150.7,137.8,132.3,130.4,129.2,128.5,128.1,127.6,125.7,124.1,122.9,121.8,121.0,120.2,119.4,118.0,117.5,110.6,18.5,14.3.HRMSm/z:+Calcd for C20H18NO 288.1383；Found 288.1376.1-naphthalen-2-ol1H NMR:δ7.87,7.83,7.78,7.35-7.28,7.18,7.12,6.96-6.93,6.88,5.30,2.95,2.21,1.89-1.78,1.53-1.48,1.33-1.30.13C{1H}NMR:δ150.8,137.9,132.4,130.4,129.2,128.1,127.9,127.6,125.3,124.8,124.1,122.8,121.9,120.1,119.8,118.1,117.5,110.7,35.6,34.1,34.0,27.0,26.9,26.5.HRMSm/z:+Calcd for C24H24NO 342.1852；Found 342.1841.1--yl)naphthalen-2-ol1H NMR:δ7.88,7.84,7.56,7.35-7.29,7.16,7.04,6.95,6.84,5.36,3.03-2.94,2.66-2.52.13C{1H}NMR:δ150.8,147.3,142.3,132.2,130.3,129.3,128.2,127.6,125.4,124.1,121.8,121.3,121.0,120.6,118.9,117.5,116.9,110.9,28.3,25.3,24.9.HRMSm/z:+Calcd for C21H18NO 300.1383；Found 300.1377.1-naphthalen-2-ol1H NMR:δ8.07,7.91,7.86,7.75,7.48,7.40,7.37-7.25,7.21-7.17,7.04,6.96,5.33.13C{1H}NMR:δ150.7,138.2,134.9,132.2,130.8,129.3,129.0,128.2,127.8,127.6,126.9,126.7,126.5,124.3,123.4,121.7,121.4,120.4,120.1,117.7,117.5,111.0.HRMSm/z:+Calcd for C24H18NO 336.1383；Found 336.1365.1--1H-indol-1-yl)naphthalen-2-ol1H NMR:δ8.00,7.93,7.87,7.71-7.68,7.38-7.36,7.35-7.32,7.28,7.22-7.16,7.04,6.97,5.30.13C{1H}NMR:δ161.8,150.7,138.0,132.1,130.9,130.8,129.3,129.1,128.2,127.8,126.64,126.62,124.3,123.5,121.6,121.5,120.1,119.2,117.6,117.4,115.9,111.0.19F NMR:δ-116.12–-116.20.HRMSm/z:+Calcd for C24H17FNO354.1289；Found 354.1281.1--1H-indol-1-yl)naphthalen-2-ol1H NMR:δ8.01,7.92,7.86,7.66,7.44,7.38-7.31,7.30-7.26,7.22-7.18,7.02,6.96,5.32.13C{1H}NMR:δ150.7,138.1,133.4,132.2,132.1,130.9,129.3,129.1,128.7,128.2,127.9,127.0,126.4,124.3,123.6,121.59,121.56,120.1,119.0,117.7,117.3,111.1.HRMSm/z:+Calcd for C24H17ClNO 370.0993；Found 370.0978.1-naphthalen-2-ol1H NMR:δ7.91,7.87-7.85,7.76-7.73,7.48,7.38-7.30,7.07-7.02,6.86,5.38,2.50.13C{1H}NMR:δ150.7,136.5,135.0,132.2,130.8,130.6,129.3,129.0,128.2,127.8,127.6,127.0,126.9,126.4,124.9,124.3,121.7,120.0,119.7,117.6,110.7,21.7.HRMSm/z:+Calcd for C25H20NO350.1539；Found 350.1530.1-naphthalen-2-ol1H NMR:δ8.03,7.92,7.86,7.70-7.68,7.48,7.40,7.38-7.32,7.14,6.99,6.86,5.32.13C{1H}NMR:δ150.6,136.6,134.2,132.0,131.0,129.3,129.1,128.3,128.1,128.0,127.7,127.6,127.3,126.8,124.4,123.7,121.4,119.9,119.8,117.7,117.1,112.1.HRMSm/z:+Calcd for C24H17ClNO 370.0993；Found370.0978.1-naphthalen-2-ol1H NMR:δ8.19,7.94,7.89-7.87,7.71,7.50,7.41,7.39-7.34,7.29,7.01,6.84,5.26.13C{1H}NMR:δ150.6,136.8,134.1,132.0,131.0,129.3,129.1,128.31,128.27,128.0,127.9,127.6,126.9,126.3,124.4,123.0,121.4,119.8,117.6,117.0,114.9,112.5.HRMSm/z:+Calcd forC24H17BrNO 414.0488；Found 414.0477.1-naphthalen-2-ol1H NMR:δ7.94-7.91,7.86,7.73,7.48,7.39-7.31,7.26,7.19,6.96,6.93,5.45,1.81.13C{1H}NMR:δ151.1,136.9,134.8,133.4,130.7,128.9,128.6,128.1,128.0,127.8,127.6,126.5,125.6,124.3,122.6,121.54,121.50,120.4,120.2,118.3,117.1,17.2.HRMSm/z:+Calcd for C25H20NO 350.1539；Found 350.1525.1-naphthalen-2-ol1H NMR:δ7.90,7.86-7.84,7.81,7.71,7.48,7.37-7.32,7.16,7.02-7.00,6.88,5.34.13C{1H}NMR:δ150.4,150.2,134.3,132.5,130.8,130.7,129.0,128.9,128.6,128.2,127.8,127.7,126.8,126.5,124.2,121.7,121.2,120.9,119.4,117.4,116.1,109.0.19F NMR:δ-135.69.HRMSm/z:+Calcd for C24H17FNO 354.1289；Found354.1286.6-Methyl-1-naphthalen-2-ol1H NMR:δ7.79,7.70,7.62,7.30,7.22-7.19,7.15-7.13,6.98,6.89-6.87,5.18,2.448-2.446.13C{1H}NMR:δ150.0,137.7,133.7,130.4,129.7,129.6,129.5,129.2,127.2,126.8,122.8,121.7,120.2,119.3,117.9,117.5,113.8,110.5,21.4,9.8.HRMSm/z:+Calcd forC20H18NO 288.1383；Found 288.1370.6-Bromo-1-naphthalen-2-ol1H NMR:δ7.99,7.78,7.71-7.69,7.36-7.33,7.23-7.19,7.17-7.13,6.95,6.85-6.82,5.34,2.44.13C{1H}NMR:δ151.0,137.6,130.9,130.8,130.3,130.1,129.4,129.3,126.5,123.8,123.1,120.4,119.4,118.8,118.2,117.9,114.3,110.4,9.8.HRMSm/z:+Calcd for C19H15BrNO352.0332；Found 352.0320.6-Hydroxy-5--2-naphthonitrile1H NMR:δ8.22,7.95,7.71,7.47,7.42,7.23,7.17,7.03,6.96,6.83,5.68,2.45.13C{1H}NMR:δ153.5,137.6,134.2,134.1,130.9,129.4,128.2,128.0,126.2,123.3,123.2,120.6,119.63,119.55,119.1,118.4,114.8,110.2,107.6,9.8.HRMSm/z:+Calcd for C20H15N2O 299.1179；Found 299.1172.6-Hydroxy-5--2-naphthaldehyde1H NMR:δ10.07,8.35,8.06,7.78,7.72,7.46,7.24,7.18-7.16,7.07,6.99,6.86,5.69,2.46.13C{1H}NMR:δ191.8,153.6,137.6,135.8,134.3,132.6,132.0,129.4,128.3,126.3,125.0,123.2,123.0,120.5,119.5,118.9,118.5,114.6,110.3,9.8.HRMSm/z:+Calcd forC20H16NO2302.1176；Found 302.1173.1-naphthalen-2-yl)ethanone1H NMR:δ8.48,8.02,7.85,7.71,7.43,7.25-7.21,7.16,7.03,6.99,6.86,5.64,2.67,2.46.13C{1H}NMR:δ197.7,153.1,137.6,134.9,132.9,132.0,130.3,129.3,128.2,126.5,125.8,123.0,122.4,120.4,119.4,118.7,118.2,114.3,110.3,26.6,9.8.HRMSm/z:+Calcd for C21H18NO2316.1332；Found 316.1326.7-Methyl-1-naphthalen-2-ol1H NMR:δ7.82,7.73,7.71,7.25,7.22-7.19,7.18-7.17,7.16-7.13,6.97,6.89,6.79,5.17,2.45,2.29.13C{1H}NMR:δ150.9,137.6,137.5,132.6,130.1,129.3,128.0,127.5,126.8,126.4,122.9,120.7,120.2,119.3,117.4,116.5,113.7,110.5,22.0,9.9.HRMSm/z:+Calcd for C20H18NO 288.1383；Found 288.1375.7-Methoxy-1-naphthalen-2-ol1H NMR:δ7.79,7.74,7.70,7.21-7.16,7.01-6.99,6.91,6.29,5.20,3.56,2.45.13C{1H}NMR:δ159.2,151.3,137.4,133.8,130.0,129.8,129.3,126.4,124.6,122.8,120.2,119.3,117.3,116.2,114.8,114.0,110.6,100.7,55.2,9.8.HRMSm/z:+Calcd forC20H18NO2304.1332；Found 304.1320.7-Ethoxy-1-naphthalen-2-ol1H NMR:δ7.79,7.74,7.70,7.21,7.18-7.14,7.01-6.99,6.91,6.28,5.18,3.81-3.71,2.45,1.27.13C{1H}NMR:δ158.5,151.3,137.4,133.8,130.0,129.7,129.3,126.5,124.5,122.8,120.1,119.2,117.2,116.5,114.7,113.9,110.6,101.5,63.4,14.5,9.8.HRMSm/z:+Calcd for C21H20NO2318.1489；Found 318.1481.7-Bromo-1-naphthalen-2-ol1H NMR:δ7.84,7.72-7.69,7.43,7.34,7.23,7.20,7.18-7.17,6.96,6.87,5.28,2.46.13C{1H}NMR:δ151.6,137.3,133.6,130.3,129.8,129.3,127.68,127.65,126.3,124.0,123.1,122.3,120.4,119.5,118.0,117.2,114.4,110.2,9.9.HRMSm/z:+Calcd forC19H15BrNO 352.0332；Found 352.0314.1-naphthalene-2,7-diol1H NMR:δ7.76,7.70,7.64,7.18-7.08,6.92,6.90-6.85,6.13,5.34,4.83,2.40.13C{1H}NMR:δ155.1,151.5,137.5,133.9,130.3,130.2,129.2,126.7,124.6,122.9,120.3,119.3,116.7,115.7,115.0,113.8,110.6,103.9,9.8.HRMSm/z:+Calcd forC19H16NO2290.1176；Found 290.1169.3-Bromo-1-naphthalen-2-ol1H NMR:δ8.18,7.77,7.70,7.37,7.32,7.21,7.15,7.01,6.98,6.86,5.69,2.45.13C{1H}NMR:δ147.7,137.6,132.5,131.7,129.3,129.2,127.9,127.2,126.6,125.2,122.9,122.3,120.3,119.4,119.3,114.0,111.4,110.5,9.8.HRMSm/z:+Calcd for C19H15BrNO 352.0332；Found 352.0318.4-Bromo-1-naphthalen-2-ol1H NMR:δ8.22,7.71-7.70,7.46-7.44,7.36-7.33,7.24-7.21,7.16,6.96-6.95,6.86,5.31,2.45.13C{1H}NMR:δ150.4,137.6,133.0,129.3,128.3,127.8,127.6,126.5,125.4,124.3,123.1,122.3,121.6,120.4,119.4,117.9,114.4,110.4,9.8.HRMSm/z:+Calcd for C19H15BrNO352.0332；Found 352.0315.1--6-phenylnaphthalen-2-ol1H NMR:δ8.03,7.92,7.71,7.64-7.62,7.55,7.43,7.36-7.33,7.21,7.15,7.04,6.99,6.91,5.30,2.45.13C{1H}NMR:δ150.8,140.8,137.7,137.0,131.5,130.6,129.6,129.3,129.0,127.4,127.32,127.25,126.8,126.1,123.0,122.5,120.3,119.4,118.04,117.96,114.0,110.5,9.9.HRMSm/z:+Calcd for C25H20NO 350.1539；Found350.1531.1--6-naphthalen-2-ol1H NMR:δ8.02,7.92,7.71,7.56-7.53,7.35,7.25,7.22-7.20,7.18-7.13,7.03,7.00,6.91,5.28,2.46,2.39.13C{1H}NMR:δ150.7,137.9,137.7,137.2,137.0,131.3,130.5,129.7,129.6,129.3,127.2,127.1,126.7,125.7,122.9,122.4,120.3,119.3,117.9,114.0,110.5,21.2,9.8.HRMSm/z:+Calcd for C26H22NO 364.1696；Found 364.1683.6--1-naphthalen-2-ol1H NMR:δ7.98,7.92,7.72,7.60-7.57,7.50,7.37,7.24-7.21,7.18-7.11,7.04,7.00,6.91,5.30,2.46.13C{1H}NMR:δ162.5,150.8,137.7,136.9,136.0,131.4,130.5,129.5,129.3,128.8,127.0,126.7,125.9,123.0,122.6,120.3,119.4,118.1,117.9,115.8,114.1,110.5,9.8.19F NMR:δ-115.5–-115.6.HRMSm/z:+Calcd for C25H19FNO 368.1445；Found 368.1431.5---6-ol1H NMR:δ8.16,8.07,7.95,7.92-7.83,7.78,7.73,7.68,7.51-7.46,7.38,7.25-7.22,7.17,7.09,7.01,6.93,5.33,2.47.13C{1H}NMR:δ150.9,138.1,137.7,136.9,133.8,132.7,131.6,130.7,129.6,129.3,128.6,128.3,127.7,127.4,126.7,126.44,126.38,126.1,126.0,125.6,123.0,122.6,120.3,119.4,118.1,118.0,114.1,110.5,9.9.HRMSm/z:+Calcd for C29H22NO 400.1696；Found 400.1676.6-Cyclopentyl-1-naphthalen-2-ol1H NMR:δ7.81,7.70,7.66,7.30,7.22-7.18,7.15-7.11,6.97,6.92-6.88,5.19,3.11-3.07,2.44,2.10-2.05,1.82-1.73,1.67-1.59.13C{1H}NMR:δ150.1,142.3,137.7,130.8,129.9,129.4,129.2,127.9,126.8,125.2,122.8,121.8,120.2,119.3,117.9,117.4,113.8,110.5,45.8,34.6,34.5,25.6,9.8.HRMSm/z:+Calcd forC24H24NO 342.1852；Found 342.1842.实施例4本发明所合成的产物N-芳基吲哚类化合物3a可进行一系列反应，从而合成进一步的衍生物。例如：在15mL圆底烧瓶中，依次加入化合物3a、2-溴丙酰胺、碳酸钾和碘化钾，再加入二甲基亚砜将其溶解。将反应体系在50℃反应17小时，反应结束后冷却至室温，加入氢氧化钾，升温至150℃反应4小时，待反应结束冷却至室温，加20mL水淬灭。乙酸乙酯萃取，合并有机相，水洗干燥、过滤浓缩，硅胶柱分离得棕黄色固体产物4。1H NMR:δ7.75-7.71,7.69,7.23-7.20,7.17,7.09,7.02,6.95-6.91,6.85,3.64,2.43.13C{1H}NMR:δ141.8,137.0,133.1,129.7,129.0,128.2,128.0,127.5,126.7,122.9,122.3,121.4,119.6,119.1,118.1,116.1,112.7,110.7,9.9.HRMSm/z:+Calcd for C19H17N2273.1386；Found 273.1388.在25mL两颈瓶中，加入化合物3a和4-二甲氨基吡啶，抽真空充氩气后加入超干二氯甲烷将其溶解。随后将反应瓶置于冰水浴中，先加入吡啶，再缓慢滴加三氟甲磺酸酐，滴加完毕室温反应3小时。加水淬灭，二氯甲烷萃取。有机相水洗干燥、过滤浓缩，硅胶柱分离得到白色油状产物5。1H NMR:δ7.90,7.85,7.58,7.47-7.45,7.32,7.24,7.09,7.03,6.94,6.73,2.35.13C{1H}NMR:δ142.3,137.0,132.2,131.0,129.3,128.1,127.5,127.3,127.2,126.7,125.7,123.2,121.5,119.0,118.6,118.1,117.3,112.6,109.5,8.6.19FNMR:δ-74.0.HRMSm/z:+Calcd forC20H15F3NO3S 406.0719；Found406.0710.在25mL两颈瓶中，依次加入化合物5和1,3-双二氯化镍，抽真空充氩气，随后加入乙醚将其溶解。将反应瓶置于冰水浴中，缓慢滴加甲基碘化镁的乙醚溶液，滴加完毕后50℃反应12小时。然后，加水淬灭，二氯甲烷萃取。有机相水洗干燥、过滤浓缩，硅胶柱分离得到黄色油状产物6。1H NMR:δ7.81-7.79,7.62,7.39,7.35,7.23,7.09,7.04-7.00,6.89,6.68,2.39,2.05.13C{1H}NMR:δ136.7,133.6,132.4,131.8,131.1,127.6,127.5,127.3,126.7,125.9,125.7,124.6,122.1,121.0,118.2,117.9,110.8,109.4,16.8,8.8.HRMSm/z:+Calcd for C20H18N272.1434；Found 272.1425.向25mL两颈瓶中依次加入3a、4-二甲氨基吡啶、碳酸铯和二甲氨基甲酰氯，抽真空充氩气，随后加入丙酮将其溶解。将反应体系室温反应10小时。反应结束，乙酸乙酯萃取，有机相干燥，抽滤旋干，硅胶柱分离得到白色油状产物7。1H NMR:δ7.93,7.90,7.65-7.63,7.50,7.47-7.40,7.38-7.34,7.14,7.08,7.01,6.90-6.88,2.72,2.42,2.34.13C{1H}NMR:δ154.2,146.3,138.3,132.1,132.0,129.2,128.9,128.1,127.3,126.7,126.1,123.4,122.7,122.1,119.5,118.7,112.1,110.9,36.6,35.9,9.8.HRMSm/z:+Calcd for C22H21N2O2345.1598；Found 345.1586.向15mL反应管中，依次加入化合物7、丙烯酸乙酯、二氯合铑、六氟锑酸银、醋酸铜和干燥的乙二醇二甲醚。抽真空充氩气，将反应体系于110℃油浴中反应14小时。反应结束后，将反应体系冷却至室温，硅藻土过滤，滤液乙酸乙酯萃取，有机相干燥后，抽滤旋干，硅胶柱分离得到黄色固体产物8。1H NMR:δ8.25,7.95-7.91,7.65,7.50,7.40,7.34,7.15,7.10,7.00,6.88,6.65,4.28,2.66,2.42,2.36,1.34.13C{1H}NMR:δ166.7,153.7,145.5,138.8,138.0,132.9,131.6,128.8,128.6,128.4,128.1,127.2,126.8,123.4,122.1,121.1,121.0,119.6,118.7,112.2,110.8,60.7,36.7,36.0,14.4,9.7.HRMSm/z:+Calcd forC27H27N2O4443.1965；Found443.1951.以上实施例描述了本发明的基本原理、主要特征及优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是说明本发明的原理，在不脱离本发明原理的范围下，本发明还会有各种变化和改进，这些变化和改进均落入本发明保护的范围内。
